NEWGENE Novel Coronavirus Antigen detection product received a special TV report on Spanish local broadcaster Antena3. NEWGENE products receive great popularity and are widely recognized locally with its superior performance and convenience of use.
At present, NEWGENE Novel Coronavirus detection series products have been registered in Italy, Argentina, Peru, Ecuador etc. and have passed clinical validation in labs with good performance. NEWGENE products have been sold to over 30 countries and regions. NEWGENE is dedicated to contributing to the campaign against epidemic.
NEWGENE has developed extensive cooperation resources in world medical and health systems, and has established long-term and stable cooperation in many countries in Europe, Southeast Asia, the Middle East, Africa, Latin America and other regions, and is dedicated to providing customers with high-quality products and services. NEWGENE will continue to serve the cause of human health with its unique technical advantages.